Created at Source Raw Value Validated value
Oct. 26, 2020, 8:37 a.m. irct

[{"arm_notes": "", "treatment_id": null, "treatment_name": "TODO Treatment - OtherIntervention group: Patients are divided into four control and experimental groups (60 patients: 15 patients in each group). Routine control group with routine treatment Receiver group SVF autologous group Blood exosome group Autologous group exposed to SVF autologous fluid It should be noted that all groups receive the same common treatments", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": 149, "treatment_name": "Autologous stromal vascular fraction", "treatment_type": "Advanced therapy medicinal products (atmp)", "pharmacological_treatment": "Biological treatment"}, {"arm_notes": "", "treatment_id": 147, "treatment_name": "Autologous blood exosome", "treatment_type": "Advanced therapy medicinal products (atmp)", "pharmacological_treatment": "Biological treatment"}, {"arm_notes": "", "treatment_id": 149, "treatment_name": "Autologous stromal vascular fraction", "treatment_type": "Advanced therapy medicinal products (atmp)", "pharmacological_treatment": "Biological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]